Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats

British Journal of Pharmacology

Volumn 126, Issue 7, 1999, Pages 1537-1542

  Bentley, Jane C ^b   Bourson, Anne ^a   Boess, Frank G ^a   Fone, Kevin C F ^b   Marsden, Charles A ^b   Petit, Nadine ^a   Sleight, Andrew J ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

4 amino N (2,6 bis methylamino pyrimidin 4 yl) benzene sulphonamide; 5 HT6; Behaviour; Chewing; Locomotor activity; Ro 04 6790; Stretching; Yawning

Indexed keywords

4 AMINO N (2,6 BIS METHYLAMINO PYRIMIDIN 4 YL) BENZENE SULPHONAMIDE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; ATROPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; METHYLATROPINE; SCOPOLAMINE; SEROTONIN 6 RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MASTICATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STRETCHING; SUBCUTANEOUS DRUG ADMINISTRATION; YAWNING;

EID: 0032907531     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702445     Document Type: Article

References (28)

1. ARGIOLAS, A. & MELIS, M.R. (1998). The Neuropharmacology of yawning. Eur. J. Pharmacol., 343, 1-16.
2. ARGIOLAS, A., MELIS, M.R., STANCAMPIANO, R. & GESSA, G.L. (1990). Role of calcium in the expression of ACTH-induced stretching, yawning and penile erection. Brain Res. Bull., 24, 853-856.
3. BARTUS, R.T., DEAN, R.L., BEER, B. & LIPPA, A.S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-417.
4. 6 antisense oligonucleotide i.c.v. affects rat performance in the water maze and feeding. British Association for Psychopharmacology Meeting, Cambridge, 13 17th July 1997, P255.
5. BERTOLILI, A. & GESSA, G.L. (1981). Behavioural effects of ACTH and MSH peptides. J. Endocrinol. Invest., 4, 241-251.
6. 6 receptors stably expressed in HEK293 cells. Neuropharmacol., 36, 713-720.
7. 3H]Ro 63-0563 labels 5-HT receptor binding sites in rat and porcine striatum. Molecular Pharmacol., 54, 577-583.
8. 6 receptor in the rat brain: A study using antisense oligonucleotides. J. Pharmacol. Exp. Ther., 274, 173-180.
9. 2 dopamine receptor agonist. Psychopharmacol., 113, 172-176.
10. FERRARI, W., GESSA, G.L. & VARGIU, L. (1963). Behavioural effects induced by intracisternally injected ACTH and MSH. Ann. N. Y. Acad. Sci., 104, 330-345.
11. 6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse, 23, 164-173.
12. 6 receptor-like material in the rat central nervous system. Brain Res., 746, 207-219.
13. GESSA, G.L., PISANO, M., VARGIU, L., CRABI, F. & FERRARI, W. (1967). Stretching and yawning movements after intracerebral injection of ACTH. Rev. Can. Biol., 26, 229-236.
14. HERZ, A., TESACHEMACHER, H., HEFSTETTER, A. & KURZ, H. (1965). The importance of lipid-solubility for the central action of cholinolytic drugs. Int. J. Neuropharmacol., 4, 207-218.
15. HOYER, D. & MARTIN, G. (1997). 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacol., 36, 419-428.
16. IRWIN, S. (1968). Comprehensive observational assessment: Ia. A systematic quantitative procedure for assessing the behavioural and physiological state of the mouse. Psychopharmacologia, 13, 222-257.
17. 6 serotonin receptor. J. Neurochem., 66, 47-56.
18. MONSMA, Jr. F.J., SHEN, Y., WARD, R.P., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Molecular. Pharmacol., 43, 320-327.
19. POGGIOLO, R., BENELLI, A., ARLETTI, R., CAVAZZUTI, E. & BERTOLINI, A. (1995). Nitric oxide is involved in the ACTH-induced behavioural syndrome. Peptides, 16, 1263-1268.
20. ROTH, B.L., CRAIGO, S.C., CHOUDHARY, M.S., ULUER, A., MONSMA, Jr. F.J., SHEN, Y., MELTZER, H.Y. & SIBLEY, D.R. (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther., 268, 403-1410.
21. 6) receptor: molecular cloning, localisation and stimulation of cAMP accumulation. Biochem. Biophys. Res., 193, 268-276.
22. 6 receptors. Brit. J. Pharmacol., 124, 556-562.
23. URBA-HOLMGREN, R., GONZALEZ, R. & HOLMGREN, B. (1977). Is yawning a cholinergic response? Nature, 267, 261-262.
24. WAHLESTEDT, C., GOLANOV, E., YAMAMOTO, S., YEE, F., ERICSON, H., YOO, H., INTRUISI, C.E. & REIS, D.J. (1993a). Antisense oligonucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature, 363, 260-263.
25. WAHLESTEDT, C., PICH, E.M., KOOB, G.F., YEE, F. & HEILIG, M. (1993b). Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science, 259, 528-531.
26. WARD, R.P., HAMBLIN, M.W., LACHOWICZ, J.E., HOFFMAN, B.J., SIBLEY, D.R. & DORSA, D.M. (1995). Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience, 64, 1105-1111.
27. YAMADA, K. & FURUKAWA, T. (1980). Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacol., 67, 39-43.
28. 2 dopamine receptors in mouse striatum. J. Pharmacol. Exp. Ther., 265, 1015-1023.